Effectiveness and Safety of Long-Term Antidepressant Treatment in Bipolar Disorder
J Clin Psychiatry 2001;62(7):565-569
© Copyright 2017 Physicians Postgraduate Press, Inc.
Purchase This PDF for $40.00
If you are not a paid subscriber, you may purchase the PDF.
(You'll need the free Adobe Acrobat Reader.)
Receive immediate full-text access to JCP. You can subscribe to JCP online-only ($86) or print + online ($156 individual).
With your subscription, receive a free PDF collection of the NCDEU Festschrift articles. Hurry! This offer ends December 31, 2011.
If you are a paid subscriber to JCP and do not yet have a username and password, activate your subscription now.
As a paid subscriber who has activated your subscription, you have access to the HTML and PDF versions of this item.
Click here to login.
Did you forget your password?
Still can't log in? Contact the Circulation Department at 1-800-489-1001 x4 or send email
Objective: We sought to review research on use
of antidepressants for long-term treatment of bipolar depression.
Method: We conducted a computerized literature
search of the MEDLINE, HealthStar, Current Contents, PsychInfo, and National Library of Medicine databases to
identify studies involving antidepressant, anticonvulsant, or
lithium use in bipolar disorder or manic-depressive illness
published from 1966 through 2000.
Results: Only 7 blinded, controlled trials of
long-term antidepressant treatment in bipolar disorders were
found. The available information is not adequate to support the
safety or effectiveness of long-term antidepressant treatment for
bipolar depression, with or without mood-stabilizing cotherapy.
Conclusion: Antidepressant treatment of bipolar
depression is extraordinarily understudied. Controlled trials
comparing specific antidepressants, particularly to compare
mood-stabilizing agents given alone and combined with an
antidepressant, are needed.